Key Points
- Insider sale: SVP Karen Bick sold 2,530 shares at an average of $46.50 for $117,645 on March 5, leaving her with 42,652 shares — a 5.60% reduction — per an SEC Form 4 filing.
- Earnings and guidance: Ralliant reported $0.69 EPS on $554.6M revenue, beating estimates, and set Q1 2026 guidance of $0.460–$0.520 and FY 2026 guidance of $2.220–$2.420 EPS.
- Dividend and analyst stance: The company announced a $0.05 quarterly dividend ($0.20 annualized, 0.4% yield), while analysts are mixed — consensus "Hold" with a $50.50 target amid recent price-target cuts and rating changes.
Ralliant Corporation (NYSE:RAL - Get Free Report) SVP Karen Bick sold 2,530 shares of Ralliant stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $46.50, for a total value of $117,645.00. Following the completion of the sale, the senior vice president directly owned 42,652 shares of the company's stock, valued at approximately $1,983,318. This represents a 5.60% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Ralliant Stock Performance
Ralliant stock opened at $44.97 on Tuesday. The stock has a fifty day moving average price of $48.82 and a 200 day moving average price of $46.72. Ralliant Corporation has a 52 week low of $37.27 and a 52 week high of $57.02. The firm has a market capitalization of $5.03 billion and a P/E ratio of 22.94. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38.
Ralliant (NYSE:RAL - Get Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.67 by $0.02. The business had revenue of $554.60 million during the quarter, compared to analyst estimates of $543.04 million. Ralliant's revenue for the quarter was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.
Ralliant Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be given a $0.05 dividend. The ex-dividend date of this dividend is Monday, March 9th. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. Ralliant's dividend payout ratio (DPR) is currently 10.20%.
Wall Street Analyst Weigh In
Several brokerages recently commented on RAL. Citigroup dropped their price target on shares of Ralliant from $61.00 to $51.00 and set a "buy" rating for the company in a research report on Friday, February 6th. Vertical Research upgraded shares of Ralliant from a "hold" rating to a "buy" rating and set a $45.00 price target on the stock in a report on Friday, February 6th. Zacks Research cut shares of Ralliant from a "hold" rating to a "strong sell" rating in a research note on Monday, February 9th. Barclays dropped their price objective on Ralliant from $60.00 to $52.00 and set an "overweight" rating for the company in a report on Monday, February 9th. Finally, Weiss Ratings lowered Ralliant from a "hold (c)" rating to a "sell (d)" rating in a research report on Thursday, February 5th. Seven analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Ralliant presently has an average rating of "Hold" and a consensus target price of $50.50.
Read Our Latest Report on Ralliant
Institutional Trading of Ralliant
A number of institutional investors and hedge funds have recently bought and sold shares of RAL. Danske Bank A S acquired a new position in Ralliant during the fourth quarter valued at approximately $25,000. Westfuller Advisors LLC purchased a new stake in Ralliant during the third quarter worth approximately $26,000. V Square Quantitative Management LLC acquired a new stake in shares of Ralliant in the fourth quarter worth $26,000. Allworth Financial LP raised its stake in shares of Ralliant by 134.4% in the 4th quarter. Allworth Financial LP now owns 511 shares of the company's stock valued at $26,000 after acquiring an additional 293 shares during the period. Finally, Palisade Asset Management LLC purchased a new position in shares of Ralliant in the 3rd quarter valued at $26,000.
Ralliant Company Profile
(
Get Free Report)
Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
